Novo Nordisk to seek regulatory approval for CagriSema obesity drug early 2026
Novo Nordisk said on Wednesday it plan to file its experimental next-generation obesity drug CagriSema for regulatory ...
Novo Nordisk's next-gen obesity drug Cagrisema: investors seek answers
Novo Nordisk is under pressure from investors for more information about its next-generation obesity drug candidate CagriSema ...
Will This New GLP-1 Drug be More Powerful Than Ozempic?
CagriSema combines semaglutide, the active ingredient in Wegovy, with a molecule that mimics a pancreatic hormone.
Investors seek answers on Novo Nordisk's next-gen obesity drug CagriSema
Novo Nordisk is under pressure from investors for more information about its next-generation obesity drug candidate CagriSema ...
The New York Times1d
The Learning Network
Have you been paying attention to current events recently? See how many of these 10 questions you can get right. Compiled by Jeremy Engle Is there a goal you’d like to pursue by doing ...
KING518h
New Day Northwest
New Day Northwest is Seattle's #1 morning talk show hosted by Kelly Hanson. Where local, national, and international celebrities, top chefs, entertainers, authors, entrepreneurs, influencers and ...